Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

被引：0
|
作者：
Schmidt, MK
van Sprundel, TC
Rookus, MA
Brohet, R
van Asperen, CJ
Rutgers, EJT
Tollenaar, RAEM
van't Veer, LJ
机构：
[1] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands
[4] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands
来源：
BREAST CANCER RESEARCH | 2005年 / 7卷 / Suppl 2期
关键词：
Breast Cancer; Contralateral Breast Cancer; BRCA2 Mutation Carrier; Mutation Testing; Contralateral Prophylactic Mastectomy;
D O I：
10.1186/bcr1096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [41] Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations
    Miller, LA
    Singer, ME
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (23): : 3070 - 3070
  • [42] Efficacy of contralateral prophylactic mastectomy in BRCA1/2 mutation carriers with previous unilateral breast cancer
    Meijers-Heijboer, H
    Menke-Pluymers, M
    Seynaeve, C
    van Putten, W
    Tilanus-Linthorst, M
    Crepin, E
    ven Geel, B
    Brekelmans, C
    Klijn, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S99 - S99
  • [43] Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
    Heemskerk-Gerritsen, Bernadette A. M.
    Jager, Agnes
    Koppert, Linetta B.
    Obdeijn, A. Inge-Marie
    Collee, Margriet
    Meijers-Heijboer, Hanne E. J.
    Jenner, Denise J.
    Oldenburg, Hester S. A.
    van Engelen, Klaartje
    de Vries, Jakob
    van Asperen, Christi J.
    Devilee, Peter
    Blok, Marinus J.
    Kets, C. Marleen
    Ausems, Margreet G. E. M.
    Seynaeve, Caroline
    Rookus, Matti A.
    Hooning, Maartje J.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (03) : 723 - 733
  • [44] Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
    Bernadette A. M. Heemskerk-Gerritsen
    Agnes Jager
    Linetta B. Koppert
    A. Inge-Marie Obdeijn
    Margriet Collée
    Hanne E. J. Meijers-Heijboer
    Denise J. Jenner
    Hester S. A. Oldenburg
    Klaartje van Engelen
    Jakob de Vries
    Christi J. van Asperen
    Peter Devilee
    Marinus J. Blok
    C. Marleen Kets
    Margreet G. E. M. Ausems
    Caroline Seynaeve
    Matti A. Rookus
    Maartje J. Hooning
    Breast Cancer Research and Treatment, 2019, 177 : 723 - 733
  • [45] Increased risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers after breast-conserving therapy compared to mastectomy
    Schmutzler, R. K.
    Graeser, M. K.
    Rhiem, K.
    Schlehe, B.
    Hofmann, W.
    Jonat, W.
    Schoenbuchner, I.
    Kiechle-Bahat, M.
    Strunz, K.
    Engel, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Kuchenbaecker, Karoline B.
    Hopper, John L.
    Barnes, Daniel R.
    Phillips, Kelly-Anne
    Mooij, Thea M.
    Roos-Blom, Marie-Jose
    Jervis, Sarah
    van Leeuwen, Flora E.
    Milne, Roger L.
    Andrieu, Nadine
    Goldgar, David E.
    Terry, Mary Beth
    Rookus, Matti A.
    Easton, Douglas F.
    Antoniou, Antonis C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (23): : 2402 - 2416
  • [47] Contralateral Breast Cancer in BRCA1/BRCA2 Mutation Carriers: The Story of the Other Side
    Garber, Judy E.
    Golshan, Mehra
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5862 - 5864
  • [48] Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers A Complex Discussion
    Domchek, Susan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (01): : 27 - 28
  • [49] Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Jan Lubinski
    Henry T. Lynch
    Nadine Tung
    Susan Armel
    Leigha Senter
    Christian F. Singer
    Robert Fruscio
    Fergus Couch
    Jeffrey N. Weitzel
    Beth Karlan
    William D. Foulkes
    Pal Moller
    Andrea Eisen
    Peter Ainsworth
    Susan L. Neuhausen
    Olufunmilayo Olopade
    Ping Sun
    Jacek Gronwald
    Steven A. Narod
    Breast Cancer Research and Treatment, 2019, 175 : 443 - 449
  • [50] Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Lynch, Henry T.
    Tung, Nadine
    Armel, Susan
    Senter, Leigha
    Singer, Christian F.
    Fruscio, Robert
    Couch, Fergus
    Weitzel, Jeffrey N.
    Karlan, Beth
    Foulkes, William D.
    Moller, Pal
    Eisen, Andrea
    Ainsworth, Peter
    Neuhausen, Susan L.
    Olopade, Olufunmilayo
    Sun, Ping
    Gronwald, Jacek
    Narod, Steven A.
    Pal, Tuya
    Wiesner, Georgia
    Eng, Charis
    Bordeleau, Louise
    Friedman, Eitan
    Meschino, Wendy
    Snyder, Carrie
    Metcalfe, Kelly
    Poll, Aletta
    Gojska, Nicole
    Warner, Ellen
    Rosen, Barry
    McCuaig, Jeanna
    Demsky, Rochelle
    Panabaker, Karen
    Steele, Linda
    Saal, Howard
    Wood, Marie
    McKinnon, Wendy
    Lemire, Edmond
    Serfas, Kim
    Sweet, Kevin
    Panchal, Seema
    Elser, Christine
    Cullinane, Carey A.
    Reilly, Robert E.
    Blum, Joanne L.
    Kwong, Ava
    Cybulski, Cezary
    Huzarski, Tomasz
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (02) : 443 - 449
12345